NATURE’S SUNSHINE PRODUCTS, INC. Notes Payable, Noncurrent
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Notes Payable, Noncurrent of $216.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermNotesPayable · last filed 2022-11-03
- 2022-09-30: Notes Payable, Noncurrent $216.00K.
- 2022-06-30: Notes Payable, Noncurrent $537.00K.
- 2022-03-31: Notes Payable, Noncurrent $857.00K.
- 2021-12-31: Notes Payable, Noncurrent $1.17M.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2022-09-30 | $216.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $537.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $857.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.17M 10-Q · filed 2022-11-03 |
| 2021-09-30 | $1.49M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.80M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $2.11M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $2.42M 10-Q · filed 2021-11-04 |
| 2020-09-30 | $2.06M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $2.97M 10-Q · filed 2020-08-06 |
| 2019-12-31 | $0.00 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |